Testing effectiveness (Phase 2)Active Not RecruitingNCT05849610
What this trial is testing
Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma
Who this might be right for
High-Risk de Novo Multiple Myeloma
PETHEMA Foundation 30